Aim-To investigate the role of oestrogen and progesterone receptor status in uterine carcinosarcomas (mixed Millerian tumours) to see whether the receptors were identifiable, and if so whether they were of significance clinically. Methods-l1 cases of uterine carcinosarcoma were identified from clinical and pathology records. An immunohistochemical method was used to demonstrate oestrogen and progesterone hormone receptors on paraffin embedded material, with suitable tissue controls, staining being recorded. Results-l0 of 1I cases showed staining for one or both hormone receptors in normal tissue adjacent to tumour. In four carcinosarcoma cases, staining for one or both receptors was shown within the epithelial component (appearing to correlate with the degree of epithelial differentiation); two of these cases had staining within sarcomatous areas. Two of the three patients still alive had epithelial hormone receptor positivity. Conclusions-Receptors for oestrogen and progesterone were found in four of 1I cases of uterine carcinosarcoma, using paraffin embedded material. There may be an association between hormone receptor positivity and clinical outcome.
The growth of many tumours is known to be promoted by hormones. Sex hormones play a role in several gynaecological neoplasms, for example endometrial adenocarcinomal-' and a range of gynaecological sarcomas.4-9 Several reports on the response to hormone treatment in these latter tumours have now been published.9 Most papers on the hormone receptor status of uterine sarcomas have concentrated on endometrial stromal sarcomas.7 [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] In some studies of gynaecological malignancies hormone receptors have been investigated in homogenised tissue,2 6 7 while in others tissue sections have also been examined immunohistochemically.`Recent reports have suggested that prognosis in carcinosarcomas (mixed Mullerian tumours) may be related to the epithelial component,14 15 and it has also been suggested that the epithelial component in other gynaecological tumours is hormone dependent. ' In light of these findings we decided to look for evidence of hormone receptors in uterine carcinosarcomas, and if they were present, whether the pattern and type of staining bore any relation to tissue components within the tumours or to clinical outcome.
Methods

PATIENTS
The databases of the departments of gynaecological oncology and histopathology at the Queen Elizabeth Hospital, Gateshead, were searched for cases of uterine carcinosarcoma. Of the cases identified, only 11 had sufficient histological material for the study. These comprised nine heterologous and two homologous uterine carcinosarcomas (tables 1 and 2).
Clinicopathological details are shown in tables 1 and 2. All patients were postmenopausal. One patient died four days postoperatively from a pulmonary embolus. In five patients a lymph node dissection was performed. In two of these, metastases were found.
Of the seven patients who developed recurrent disease, only two had local (pelvic) recurrence. The remaining five patients developed abdominal, hepatic, and pulmonary metastases, in two cases in addition to pelvic recurrence. At the time of writing three patients were alive and well at 12, 48, and 84 months, respectively after primary treatment.
Clinical data regarding age, stage (according to the 1988 FIGO staging for endometrial carcinoma), tumour size, menopausal status, time to recurrence, localisation of recurrence, and current status were collected from the database and the original case notes (AA). The original slides were reviewed by one of the authors (PC). Histopathological data were collected on tumour type and components present, depth of myometrial invasion, mitotic rate, vascular space involvement, and lymph node status.
PROCEDURES
The paraffin processed blocks of the cases were identified, along with the original sections and reports. Blocks containing the tumour elements as well as those containing normal uterine tissue (ifpresent) were identified. Commercial monoclonal mouse antihuman oestrogen receptor antibody (Dako-ER, ID5, Dako, Glostrup, Denmark) and mouse monoclonal antihuman progesterone receptor antibody (fig 1) .
Most of the tumours were negative for both receptors. Only four cases showed focal positivity for one (or both) receptors (fig 2) , and then mainly in the epithelial component of the tumour (one well differentiated endometrioid, two moderately well differentiated endometrioid, and one poorly differentiated serous). Two showed positivity in the sarcomatous area, these being classed as sarcoma not otherwise specifiable.
The positive as well as the negative controls were appropriately stained throughout (fig 3) . tissue in the same cases is related to the technique itself.
Whether patients with hormone receptor positive tumours have a better prognosis remains to be established and the present series is too small to draw any conclusions in this respect. Three out of 11 patients were alive and well at the time of writing. Two of these had hormone receptor positivity in the epithelial uterine carcinosarcoma component, whereas in only two out of eight patients who developed a recurrence and subsequently died of the disease was tumour hormone receptor positivity found (interestingly in both adenocarcinomatous and sarcoma NOS areas). Recently it has been shown that prognosis is correlated with the type and degree of differentiation of the epithelial component in uterine carcinosarcoma. 4 From our small study there seems to be a trend for patients with better differentiated adenocarcinomatous elements in their tumours to survive longer, but survival does not correlate completely with the receptor status (tables 1 and 3). 
